Clinical Trial Update: A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer. [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial for platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Eli Lilly and Company | Conditions: Genital Neoplasms, Female, Fallopian Tube Neoplasms | Phase 3 | Status: COMPLETED